Grindeks AS | Income Statement

Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
118,461.10
88,487.50
82,662.30
105,366.50
132,410.90
134,350.80
Cost of Goods Sold (COGS) incl. D&A
45,892.10
39,014.50
45,217.30
48,034.60
56,393.80
62,227
Gross Income
72,569.00
49,473.00
37,445.00
57,331.90
76,017.10
72,123.80
SG&A Expense
39,042.30
36,764.20
31,292.50
38,201.50
50,939.00
57,988.60
EBIT
7,896.90
4,610.40
6,860.70
-
21,889.40
6,653.10
Unusual Expense
224.00
-
-
-
-
153.40
Non Operating Income/Expense
8,278.50
2,961.70
8,809.00
9,755.20
12,779.50
1,699.60
Interest Expense
254.90
417.10
706.70
594.80
491.50
498.20
Pretax Income
16,291.50
1,901.20
1,442.60
6,170.20
8,807.30
8,841.80
Income Tax
2,782.30
635.00
395.50
1,609.60
1,161.10
895.10
Consolidated Net Income
13,509.20
2,536.20
1,047.00
4,560.60
9,968.40
9,736.90
Net Income
13,505.30
2,540.20
1,036.70
4,571.10
9,958.20
9,732.40
Net Income After Extraordinaries
13,505.30
2,540.20
1,036.70
4,571.10
9,958.20
9,732.40
Net Income Available to Common
13,505.30
2,540.20
1,036.70
4,571.10
9,958.20
9,732.40
EPS (Basic)
1.41
0.27
0.11
0.48
1.04
1.02
Basic Shares Outstanding
9,585.00
9,585.00
9,585.00
9,585.00
9,585.00
9,585
EPS (Diluted)
1.41
0.27
0.11
0.48
1.04
1.02
Diluted Shares Outstanding
9,585.00
9,585.00
9,585.00
9,585.00
9,585.00
9,585
EBITDA
12,594.30
567.30
963.20
22,029.10
27,827.80
906.50
Other Operating Expense
25,629.80
17,319.20
13,013.30
2,799.90
3,188.60
20,788.40
Non-Operating Interest Income
147.00
164.70
201.00
189.60
188.90
162.40
Minority Interest Expense
4.00
4.00
10.30
10.50
10.20
4.50

About Grindeks AS

View Profile
Address
Krustpils iela 53
Riga RA LV
Latvia
Employees -
Website http://www.grindeks.lv
Updated 07/08/2019
Grindeks PJSC is a pharmaceutical company, which engages in the research, development, manufacture, and sale of original products, generics, and active pharmaceutical products. Its services include registration, contract manufacturing, and analytical. The company was founded in 1946 and is headquartered in Riga, Latvia.